M. Kopf, C. Schneider, and S. P. Nobs, The development and function of lungresident macrophages and dendritic cells, Nat Immunol, vol.16, issue.1, pp.36-44, 2015.

C. C. Garcia, R. Guabiraba, F. M. Soriani, and M. M. Teixeira, The development of anti-inflammatory drugs for infectious diseases, Discov Med, issue.55, pp.479-88, 2010.

R. K. Gupta, R. George, and J. S. Nguyen-van-tam, Bacterial pneumonia and pandemic influenza planning, Emerg Infect Dis, vol.14, issue.8, pp.1187-92, 2008.

K. R. Short, M. N. Habets, P. W. Hermans, and D. A. Diavatopoulos, Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship?, Future Microbiol, vol.7, issue.5, pp.609-633, 2012.

J. A. Mccullers, Insights into the interaction between influenza virus and pneumococcus, Clin Microbiol Rev, vol.19, issue.3, pp.571-82, 2006.

S. A. Madhi and K. P. Klugman, Vaccine Trialist G. A role for Streptococcus pneumoniae in virus-associated pneumonia, Nat Med, vol.10, issue.8, pp.811-814, 2004.

A. Karlström, S. M. Heston, K. L. Boyd, E. I. Tuomanen, and J. A. Mccullers, Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenza, J Infect Dis, vol.204, issue.9, pp.1358-66, 2011.

J. P. Wang, G. N. Bowen, C. Padden, A. Cerny, R. W. Finberg et al., Toll-like receptor-mediated activation of neutrophils by influenza A virus, Blood, vol.112, issue.5, pp.2028-2062, 2008.

R. José, A. Williams, M. Sulikowski, D. Brealey, J. Brown et al., Regulation of neutrophilic inflammation in lung injury induced by community-acquired pneumonia, Lancet, issue.1, pp.60367-60368, 2015.

J. V. Camp and C. B. Jonsson, A role for neutrophils in viral respiratory disease, Front Immunol, vol.8, p.550, 2017.

R. C. Russo, C. C. Garcia, M. M. Teixeira, and F. A. Amaral, The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases, Expert Rev Clin Immunol, vol.10, issue.5, pp.593-619, 2014.

I. Ramos and A. Fernandez-sesma, Modulating the innate immune response to influenza A virus: potential therapeutic use of anti-inflammatory drugs, Front Immunol, vol.6, p.361, 2015.

L. P. Tavares, C. C. Garcia, J. P. Vago, C. M. Queiroz-junior, I. Galvão et al., Inhibition of PDE4 during pneumococcal pneumonia reduces inflammation and lung injury in mice, Am J Respir Cell Mol Biol, vol.55, issue.1, pp.24-34, 2015.

T. M. Cunha, M. M. Barsante, A. T. Guerrero, W. A. Verri, S. H. Ferreira et al., Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice, Br J Pharmacol, vol.154, issue.2, pp.460-70, 2008.

C. C. Garcia, R. C. Russo, R. Guabiraba, C. T. Fagundes, R. B. Polidoro et al., Platelet-activating factor receptor plays a role in lung injury and death caused by influenza A in mice, PLoS Pathog, vol.6, issue.11, p.1001171, 2010.

R. C. Russo, R. Guabiraba, C. C. Garcia, L. S. Barcelos, E. Roffê et al., Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis, Am J Respir Cell Mol Biol, vol.40, issue.4, pp.410-431, 2009.

K. Mihara, M. Spansier, M. Rooseboom, M. J. Smit, and W. Dokter, Functional replacement of murine CXCR2 by its human homologue in the development of atherosclerosis in LDLR knockout mice, Biol Pharm Bull, vol.30, issue.7, pp.1231-1237, 2007.

W. Fu, Y. Zhang, J. Zhang, and W. F. Chen, Cloning and characterization of mouse homolog of the CXC chemokine receptor CXCR1, Cytokine, vol.31, issue.1, pp.9-17, 2005.

E. Y. Klein, B. Monteforte, A. Gupta, W. Jiang, L. May et al., The frequency of influenza and bacterial co-infection: a systematic review and meta-analysis. Influenza Other Respir Viruses, vol.10, pp.394-403, 2016.

G. Palacios, M. Hornig, D. Cisterna, N. Savji, A. V. Bussetti et al., Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza, PLoS One, vol.4, issue.12, p.8540, 2009.

S. Jain, L. Kamimoto, A. M. Bramley, A. M. Schmitz, S. R. Benoit et al., Hospitalized patients with 2009 H1N1 influenza in the United States, N Engl J Med, issue.20, pp.1935-1979, 2009.

G. Dominguez-cherit, S. E. Lapinsky, A. E. Macias, R. Pinto, L. Espinosa-perez et al., Critically Ill patients with 2009 influenza A(H1N1) in Mexico, JAMA, vol.302, issue.17, pp.1880-1887, 2009.

D. M. Morens, J. K. Taubenberger, and A. S. Fauci, Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness, J Infect Dis, vol.198, issue.7, pp.962-70, 2008.

D. Tasher, M. Stein, E. A. Simões, T. Shohat, M. Bromberg et al., Invasive bacterial infections in relation to influenza outbreaks, Clin Infect Dis, vol.53, issue.12, pp.1199-207, 2006.

D. C. Blok, K. F. Van-der-sluijs, S. Florquin, O. J. De-boer, C. Van-'t-veer et al., Limited anti-inflammatory role for interleukin-1 receptor like 1 (ST2) in the host response to murine postinfluenza pneumococcal pneumonia, PLoS One, vol.8, issue.3, p.58191, 2013.

L. A. Mandell, R. G. Wunderink, A. Anzueto, J. G. Bartlett, G. D. Campbell et al., Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults, Clin Infect Dis, issue.2, pp.27-72, 2007.

E. Tuomanen, R. Rich, and O. Zak, Induction of pulmonary inflammation by components of the pneumococcal cell surface, Am Rev Respir Dis, vol.135, issue.4, pp.869-74, 1987.

E. Estenssoro, F. G. Ríos, C. Apezteguía, R. R. Neira, J. Ceraso et al., Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation, Am J Respir Crit Care Med, vol.182, issue.1, pp.41-49, 2010.

H. E. Ghoneim and J. A. Mccullers, Adjunctive corticosteroid therapy improves lung immunopathology and survival during severe secondary pneumococcal pneumonia in mice, J Infect Dis, vol.209, issue.9, pp.1459-68, 2014.

K. V. Sawant, R. Xu, R. Cox, H. Hawkins, E. Sbrana et al., Chemokine CXCL1-mediated neutrophil trafficking in the lung: role of CXCR2 activation, J Innate Immun, vol.7, issue.6, pp.647-58, 2015.

A. M. Ritzman, J. M. Hughes-hanks, V. A. Blaho, L. E. Wax, W. J. Mitchell et al., The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis, Infect Immun, issue.11, pp.4593-600, 2010.

J. L. Mcauley, K. Kedzierska, L. E. Brown, and G. D. Shanks, Host immunological factors enhancing mortality of young adults during the 1918 influenza pandemic, Front Immunol, vol.6, p.419, 2015.

A. Planagumà, T. Domènech, M. Pont, E. Calama, V. García-gonzález et al., Combined anti CXC receptors 1 and 2 therapy is a promising antiinflammatory treatment for respiratory diseases by reducing neutrophil migration and activation, Pulm Pharmacol Ther, vol.34, pp.37-45, 2015.

A. H. Lopes, L. Brandolini, A. Aramini, G. Bianchini, R. L. Silva et al., DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain, Pharmacol Res, vol.103, pp.69-79, 2016.

N. B. Boppana, A. Devarajan, K. Gopal, M. Barathan, S. A. Bakar et al., Blockade of CXCR2 signalling: a potential therapeutic target for preventing neutrophil-mediated inflammatory diseases, Exp Biol Med, issue.5, pp.509-527, 2014.

M. D. Wareing, A. L. Shea, C. A. Inglis, P. B. Dias, and S. R. Sarawar, CXCR2 is required for neutrophil recruitment to the lung during influenza virus infection, but is not essential for viral clearance, Viral Immunol, vol.20, issue.3, pp.369-78, 2007.

M. P. Deberge, K. H. Ely, G. S. Cheng, and R. I. Enelow, ADAM17-mediated processing of TNF-alpha expressed by antiviral effector CD8+ T cells is required for severe T-cell-mediated lung injury, PLoS One, vol.8, issue.11, p.79340, 2013.

M. Seki, S. Kohno, M. W. Newstead, X. Zeng, U. Bhan et al., Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia, J Immunol, vol.184, issue.3, pp.1410-1418, 2010.

B. Ghanem, E. N. Clark, S. Roggensack, S. E. Mciver, S. R. Alcaide et al., Extracellular adenosine protects against Streptococcus pneumoniae lung infection by regulating pulmonary neutrophil recruitment, PLoS Pathog, vol.11, issue.8, p.1005126, 2015.

H. Echchannaoui, K. Frei, M. Letiembre, R. M. Strieter, Y. Adachi et al., CD14 deficiency leads to increased MIP-2 production, CXCR2 expression, neutrophil transmigration, and early death in pneumococcal infection, J Leukoc Biol, vol.78, issue.3, pp.705-720, 2005.

W. Herbold, R. Maus, I. Hahn, N. Ding, M. Srivastava et al., Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage recruitment in response to pneumococcal lung infection, Infect Immun, issue.6, pp.2620-2650, 2010.

L. A. Pittet, L. Hall-stoodley, M. R. Rutkowski, and A. G. Harmsen, Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae, Am J Respir Cell Mol Biol, vol.42, issue.4, pp.450-60, 2010.

V. T. Peltola, K. G. Murti, and J. A. Mccullers, Influenza virus neuraminidase contributes to secondary bacterial pneumonia, J Infect Dis, vol.192, issue.2, pp.249-57, 2005.

A. Rynda-apple, K. M. Robinson, and J. F. Alcorn, Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease, Infect Immun, vol.83, issue.10, pp.3764-70, 2015.

L. A. Mcnamee and A. G. Harmsen, Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection, Infect Immun, vol.74, issue.12, pp.6707-6728, 2006.

R. Vlahos, J. Stambas, and S. Selemidis, Suppressing production of reactive oxygen species (ROS) for influenza A virus therapy, Trends Pharmacol Sci, vol.33, issue.1, pp.3-8, 2012.

A. Narayana-moorthy, T. Narasaraju, P. Rai, R. Perumalsamy, K. B. Tan et al., In vivo and in vitro studies on the roles of neutrophil extracellular traps during secondary pneumococcal pneumonia after primary pulmonary influenza infection, Front Immunol, vol.4, p.56, 2013.

K. B. Walsh, J. R. Teijaro, P. R. Wilker, A. Jatzek, D. M. Fremgen et al., Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus, Proc Natl Acad Sci U S A, vol.108, issue.29, pp.12018-12041, 2011.

L. P. Tavares, M. M. Teixeira, and C. C. Garcia, The inflammatory response triggered by influenza virus: a two edged sword, Inflamm Res, vol.66, issue.4, pp.283-302, 2017.

J. Gavard, X. Hou, Y. Qu, A. Masedunskas, D. Martin et al., A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability, Mol Cell Biol, vol.29, issue.9, pp.2469-80, 2009.

S. Zhang, M. Rahman, S. Zhang, Z. Qi, H. Herwald et al., Simvastatin regulates CXC chemokine formation in streptococcal M1 protein-induced neutrophil infiltration in the lung, Am J Physiol Lung Cell Mol Physiol, vol.300, issue.6, pp.930-939, 2011.

J. Reutershan, M. A. Morris, T. L. Burcin, D. F. Smith, D. Chang et al., Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung, J Clin Invest, vol.116, issue.3, pp.695-702, 2006.

M. W. Smith, J. E. Schmidt, J. E. Rehg, C. J. Orihuela, and J. A. Mccullers, Induction of pro-and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza, Comp Med, vol.57, issue.1, pp.82-91, 2007.

K. F. Van-der-sluijs, M. Nijhuis, J. H. Levels, S. Florquin, A. L. Mellor et al., Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia, J Infect Dis, vol.193, issue.2, pp.214-236, 2006.

A. Barthelemy, S. Ivanov, J. Fontaine, D. Soulard, H. Bouabe et al., Influenza A virus-induced release of interleukin-10 inhibits the anti-microbial activities of invariant natural killer T cells during invasive pneumococcal superinfection, Mucosal Immunol, vol.10, issue.2, pp.460-469, 2016.